Shifting Rehabilitation Paradigms in Skilled Nursing Facilities

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT02927171
Collaborator
University of Colorado, Denver (Other)
104
3
2
34.1
34.7
1

Study Details

Study Description

Brief Summary

This study seeks to improve rehabilitation methods for restoring physical function with skilled nursing facility care. More specifically, this study is designed to evaluate the effectiveness of an intensive therapeutic rehabilitation program for older adult skilled nursing home residents compared to usual care.

Condition or Disease Intervention/Treatment Phase
  • Other: IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents
N/A

Detailed Description

There is growing recognition that acute hospitalization contributes to marked functional decline in older adults. Nearly 20% of all hospitalized older adults are discharged to a skilled nursing facility (SNF) to address these functional deficits. However, rehabilitation in SNFs may not adequately restore physical function, which potentially contributes to poor community discharge rates. Strikingly, only 37% of all patients admitted to SNFs are discharged to a community setting, which suggests a paradigm shift is required to optimize rehabilitation within SNFs. Currently, usual care rehabilitation in SNFs consists of low-intensity rehabilitation interventions, which are physiologically inadequate to induce meaningful changes in skeletal muscle strength and physical function. Therefore, the investigators propose a novel "IntenSive Therapeutic Rehabilitation for Older skilled NursinG HomE Residents" (I-STRONGER) program, which integrates principles of physiologic tissue overload into combined strengthening and functional interventions for greater gains in physical function. The overall goals of this investigation are to 1) demonstrate feasibility of I-STRONGER in SNF settings and 2) determine the effectiveness of I-STRONGER in improving physical function. A comparison of usual care (UC) with I-STRONGER will occur using a staged, 2 group design (independent cohorts), with a single SNF serving as its own control. The first cohort of SNF patients will participate in UC (Stage 1) and after therapist training on ISTRONGER is completed, a second cohort of patients entering the same facility will participate in I-STRONGER (Stage 2). The feasibility of I-STRONGER will be evaluated by patient acceptability and therapist compliance measures. Sample size estimates (using patients with mobility deficits in home health settings) suggest at least 86 participants are necessary to be adequately powered. Heterogeneity of the sample will be re-evaluated during the study period using SNF data and sample size estimates may be adjusted as appropriate.

Study Design

Study Type:
Interventional
Actual Enrollment :
104 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Shifting Rehabilitation Paradigms in Skilled Nursing Facilities
Actual Study Start Date :
Feb 28, 2016
Actual Primary Completion Date :
Oct 30, 2018
Actual Study Completion Date :
Jan 1, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care.

Experimental: I-STRONGER

IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care.

Other: IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents
Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
Other Names:
  • I-STRONGER
  • Outcome Measures

    Primary Outcome Measures

    1. Short Physical Performance Battery (SPPB) [Change from SNF Admission to SNF Discharge (Expected average length of stay: 21 days)]

      Global measure of lower extremity function, which consists of walking speed, chair stands, and balance tests. Minimum scores are 0 and maximum scores are 12. Higher scores indicate better function.

    Secondary Outcome Measures

    1. Gait Speed [Change from SNF Admission to SNF Discharge (Expected average length of stay: 21 days)]

      Time it takes to walk a 4 meter path. Lower scores indicate better function.

    Other Outcome Measures

    1. Patient Satisfaction Survey [Quantification at SNF Discharge (Expected average length of stay: 21 days)]

      8 Question survey, scoring each questions on a 1-10 scale (1=not at all, 10=extremely). Higher scores indicate higher satisfaction.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Adults > 18 years of age who are admitted to a skilled nursing facility following hospitalization

    2. Qualify to receive at least physical therapy services

    Exclusion Criteria:
    • Patients with primary diagnoses related to neurological disorders will be excluded as patient needs require more of a motor control approach rather than the proposed high-intensity approach. Such patient populations include:

    • Parkinson's Disease

    • Traumatic Brain Injury

    • Recent Cerebral Vascular Accident

    • Alzheimer's Disease

    • Patients on hospice care will be excluded as the approach is based on palliative principles.

    • Other patients to be excluded will include those with conditions where strength training is contraindicated (as indicated by the American College of

    Sports Medicine Guidelines for Exercise Testing and Prescription):
    • Recent unstable fracture

    • Advanced congestive heart failure

    • Bone metastasis sites

    • Tumors in strengthening target areas

    • Acute Illness

    • Recent myocardial infarction (within 3-6 weeks)

    • Weight bearing restrictions on graft or fracture sites

    • Exposed tendon or muscle

    • Absence of pedal pulses

    • Presence of fistula

    • Platelet levels <50,000/ L

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora Colorado United States 80045
    2 VA Community Living Center Aurora Colorado United States 80045
    3 Brookdale Senior Living Denver Colorado United States 80247

    Sponsors and Collaborators

    • VA Office of Research and Development
    • University of Colorado, Denver

    Investigators

    • Principal Investigator: Jennifer E. Stevens-Lapsley, PhD, Rocky Mountain Regional VA Medical Center, Aurora, CO

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT02927171
    Other Study ID Numbers:
    • E2193-P
    • I21RX002193
    First Posted:
    Oct 6, 2016
    Last Update Posted:
    Apr 3, 2020
    Last Verified:
    Mar 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by VA Office of Research and Development

    Study Results

    Participant Flow

    Recruitment Details Participants were recruited from a skilled nursing facility between the dates of 02.28.2016 and 10.30.2018
    Pre-assignment Detail There were no exclusions of participants. All eligible, willing participants were allocated to one of two arms.
    Arm/Group Title Usual Care I-STRONGER
    Arm/Group Description Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents: Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
    Period Title: Overall Study
    STARTED 53 51
    COMPLETED 53 50
    NOT COMPLETED 0 1

    Baseline Characteristics

    Arm/Group Title Usual Care I-STRONGER Total
    Arm/Group Description Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents: Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Total of all reporting groups
    Overall Participants 53 50 103
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    78.0
    (9.6)
    77.3
    (10.8)
    77.65
    (10.2)
    Sex: Female, Male (Count of Participants)
    Female
    9
    17%
    2
    4%
    11
    10.7%
    Male
    44
    83%
    48
    96%
    92
    89.3%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    2
    3.8%
    4
    8%
    6
    5.8%
    Not Hispanic or Latino
    51
    96.2%
    43
    86%
    94
    91.3%
    Unknown or Not Reported
    0
    0%
    3
    6%
    3
    2.9%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    0
    0%
    0
    0%
    Asian
    1
    1.9%
    0
    0%
    1
    1%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    16
    30.2%
    12
    24%
    28
    27.2%
    White
    34
    64.2%
    31
    62%
    65
    63.1%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    2
    3.8%
    7
    14%
    9
    8.7%
    Region of Enrollment (Count of Participants)
    United States
    53
    100%
    50
    100%
    103
    100%

    Outcome Measures

    1. Primary Outcome
    Title Short Physical Performance Battery (SPPB)
    Description Global measure of lower extremity function, which consists of walking speed, chair stands, and balance tests. Minimum scores are 0 and maximum scores are 12. Higher scores indicate better function.
    Time Frame Change from SNF Admission to SNF Discharge (Expected average length of stay: 21 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care I-STRONGER
    Arm/Group Description Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents: Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
    Measure Participants 53 50
    Mean (Standard Deviation) [score on a scale]
    3.6
    (2.3)
    4.3
    (2.7)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Usual Care
    Comments
    Type of Statistical Test Other
    Comments
    Statistical Test of Hypothesis p-Value 0.17
    Comments
    Method t-test, 1 sided
    Comments
    2. Secondary Outcome
    Title Gait Speed
    Description Time it takes to walk a 4 meter path. Lower scores indicate better function.
    Time Frame Change from SNF Admission to SNF Discharge (Expected average length of stay: 21 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care I-STRONGER
    Arm/Group Description Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents: Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
    Measure Participants 53 50
    Mean (Standard Deviation) [seconds]
    0.3
    (0.2)
    0.5
    (0.3)
    3. Other Pre-specified Outcome
    Title Patient Satisfaction Survey
    Description 8 Question survey, scoring each questions on a 1-10 scale (1=not at all, 10=extremely). Higher scores indicate higher satisfaction.
    Time Frame Quantification at SNF Discharge (Expected average length of stay: 21 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care I-STRONGER
    Arm/Group Description Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents: Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
    Measure Participants 53 50
    Mean (Standard Deviation) [score on a scale]
    54.6
    (7.9)
    59.4
    (7.3)

    Adverse Events

    Time Frame Baseline through discharge from Skilled Nursing Facility (average 21 days)
    Adverse Event Reporting Description
    Arm/Group Title Usual Care I-STRONGER
    Arm/Group Description Skilled nursing facility rehabilitation therapists provide all patients with usual standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled NursinG HomE Residents (I-STRONGER) Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities. Skilled nursing facility rehabilitation therapists will be trained in I-STRONGER intervention and will implement to all eligible patients as new standard of care. IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents: Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
    All Cause Mortality
    Usual Care I-STRONGER
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/53 (0%) 0/50 (0%)
    Serious Adverse Events
    Usual Care I-STRONGER
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/53 (0%) 0/50 (0%)
    Other (Not Including Serious) Adverse Events
    Usual Care I-STRONGER
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/53 (0%) 0/50 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Jennifer Stevens-Lapsley
    Organization University of Colorado Denver
    Phone 303.724.9170
    Email jennifer.stevens-lapsley@cuanschutz.edu
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT02927171
    Other Study ID Numbers:
    • E2193-P
    • I21RX002193
    First Posted:
    Oct 6, 2016
    Last Update Posted:
    Apr 3, 2020
    Last Verified:
    Mar 1, 2020